Previously, it was shown that the D enantiomer of isoidide dinitrate was 10-fold more potent than the L enantiomer and 10-fold less potent than glyceryl trinitrate for stimulating cyclic GMP accumulation and relaxation of isolated rat aorta. In the present study, these organic nitrates were tested for then-ability to induce tolerance to organic nitrate-induced relaxation, cyclic GMP accumulation, and guanylate cyclase activation in rat aorta in vitro. To compensate for the differences in vasodilator potency, tolerance was induced by incubating isolated rat aorta with concentrations of organic nitrates 1,000-fold greater than the ECJO for relaxation. Under these conditions, the EC M for relaxation was increased significantly for each organic nitrate and to a similar degree on subsequent reexposure. These data suggest that the potential for inducing in vitro tolerance to relaxation was the same for the three organic nitrates tested. When activation of soluble guanylate cyclase by these compounds was assessed, the enantiomers of isoidide dinitrate were equipotent, but less potent than glyceryl trinitrate, suggesting that the site of enantioselectivity is not guanylate cyclase itself. In blood vessels made tolerant to organic nitrates by pretreatment with glyceryl trinitrate, vasodilator activity, cyclic GMP accumulation, and guanylate cyclase activation were attenuated on reexposure to each organic nitrate. In addition, differences in the potency of the three organic nitrates and the enantioselectivity of isoidide dinitrate for relaxation were abolished in tolerant tissue, whereas the potency difference between glyceryl trinitrate and isoidide dinitrate for activation of guanylate cyclase was unchanged. The results suggest that there are at least two sites at which organic nitrates act: guanylate cyclase and an unidentified site that allows for enantioselectivity of vasodilation and cyclic GMP accumulation. Furthermore, when blood vessels are made tolerant to organic nitrates, the enantioselectivity and the differences in potency of the organic nitrates for relaxation are lost, and activation of guanylate cyclase is decreased. (Circulation Research 1988;63:693-701)
made tolerant to the relaxant effect of GTN. 5 Furthermore, in GTN-tolerant vascular tissues, accumulation of cyclic GMP and activation of guanylate cyclase by organic nitrates was attenuated. 6 -' 2 Thus, there appears to be a close association between the mechanism underlying organic nitrate action, tolerance, and biotransformation.
The dinitrate esters of l,4:3,6-dianhydrohexitol exist in three stereoisomeric forms and differ in the spatial orientation of the nitrate ester groups ( Figure  1 ). For isoidide dinitrate (IIDN), both nitrate groups are in the exo position. Isomannide dinitrate (IMDN) contains two endo nitrate groups, whereas isosorbide dinitrate (ISDN) has one exo and one endo nitrate group. Studies comparing the relative vasodilator activity of the three isomers demonstrated an order of potency of UDN>ISDN>IMDN. 1314 Presumably this difference in potency is related to the configuration of the nitrate ester groups since the three isomers are otherwise identical. In addition to the positional isomerism discussed above, each of these compounds is optically active. Only one enantiomer of each has been studied experimentally or clinically, since optical activity is retained after synthesis from the naturally occurring sugar alcohols, D-sorbitol, D-mannitol, and L-iditol. Recently we synthesized for the first time the D enantiomer of IIDN and found that it was 10-fold more potent than L-IIDN for stimulation of cyclic GMP accumulation and for relaxation of isolated rat aorta.
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The major objective of the current study was to further characterize the potency difference between r> and L-IIDN with respect to possible sites of enantioselectivity. One possible site could be selectivity for activation of guanylate cyclase. Another site for enantioselectivity could be in the biotransformation of IIDN to an active species. To examine this possibility, the effect of in vitro GTN tolerance on relaxation, cyclic GMP accumulation, and activation of guanylate cyclase by r> and L-IIDN was assessed, since GTN-induced tolerance is associated with a decrease in GTN biotransformation.
Development of tolerance to the vasodilator effect of D-or L-IIDN has not been examined, and another objective was to compare the potential of r> and L-IIDN with that of GTN for inducing in vitro tolerance.
Materials and Methods

Drugs and Solutions
Krebs' solution was composed of the following (mM): NaCl 118, KC1 4.74, MgSO 4 17 in that reagent volumes were reduced by a factor of 20 and a KN0 3 standard curve was used rather than a single KN0 3 concentration. All other chemicals were of reagent grade and were obtained from a variety of sources.
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Relaxation Studies
Male Sprague-Dawley rats (200-250 g) were decapitated and the thoracic aorta removed and cut into helical strips (approximately 2 mm x 1.5 cm, three strips per aorta). The strips were suspended in individual tissue baths containing 15 ml Krebs' solution, and isometric responses were recorded using force displacement transducers (FTO3C, Grass Instruments, Quincy, Massachusetts) coupled to a Grass Model 7 polygraph. The strips were maintained at a resting tension of 0.4 g for the 1-hour equilibration period, during which the Krebs' solution was changed every 15 minutes. Tissues were contracted submaximally with 0.3 /AM norepinephrine, and after 10 minutes cumulative concentration-response curves for GTN, D-IIDN, or L-IIDN were obtained. The strips were washed for 30 minutes and organic nitrate tolerance was induced by one of two protocols. For "high-dose" organic nitrate tolerance, all strips were incubated with 0.5 mM GTN for 1 hour. The tissues were washed for 1 hour, contracted with 0.3 fiM. norepinephrine, and cumulative concentrationresponse curves were repeated for GTN, D-IIDN, or L-IIDN. For "low-dose" organic nitrate tolerance, the ECJO value for relaxation by the three organic nitrates in the first concentration-response curve was calculated, and each strip was incubated for 1 hour with a concentration of organic nitrate that was 1,000-fold greater than the EC30. Tissues were washed for 1 hour, contracted with 0.3 ^.M norepinephrine, and concentration-response curves were repeated. To control for possible timedependent changes in the sensitivity of the tissues to organic nitrates, a parallel series of experiments were performed in which tissues were incubated with appropriate dilutions of ethanol in Krebs' solution rather than with organic nitrates.
Cyclic GMP Measurements
Four aortic strips were prepared from each rat and were incubated individually in flasks. After equilibration, two strips were incubated with 0.5 mM GTN for 1 hour and the other two strips were incubated with the appropriate concentration of ethanol (<0.2%) in Krebs' solution. Tissues were washed for 1 hour, exposed to 0.3 ^M norepinephrine for 10 minutes, and then to the organic nitrates at the concentrations and for the times indicated. Tissues were frozen between liquid-nitrogen precooled clamps and cyclic GMP levels were assayed as described previously. 18 Briefly, frozen tissues were homogenized in 6% trichloroacetic acid and then centrifuged. Supernatant fractions were extracted with diethyl ether, acetylated, 19 and cyclic GMP quantified by radioimmunoassay. 20 Protein was determined by the method of Lowry et al 21 using bovine serum albumin as the standard. In previous studies from this laboratory, both basal cyclic GMP levels and elevated cyclic GMP levels induced by various agents were similar when tissues were mounted under tension in tissue baths or placed in flasks. 18 -22 Guanylate Cyclase Activity Aortas from three rats were pooled for determination of guanylate cyclase activity. Each aorta was cut open longitudinally and then divided in half. One segment was incubated with 0.5 mM GTN for 1 hour and the other served as control and was incubated with the appropriate volume of ethanol (<0.2%) in Krebs' solution. The segments were washed for 1 hour and then homogenized in icecold buffer containing 50 mM Tris-HCl (pH 7.6), 0.5 mM dithiothreitol, 1.0 mM EDTA, and 0.25 M sucrose. Homogenates were centrifuged at 105,000# for 1 hour and the resulting supernatant fraction was used immediately for guanylate cyclase determinations. Guanylate cyclase activity was assayed essentially as described. 23 Incubations (100 i*\ for 10 minutes at 37° C) contained 50 mM Tris-HCl (pH 7.6), 0.5 mM isobutylmethylxanthine, a GTP regenerating system consisting of 3.5 mM creatine phosphate and 6 jig creatine phosphokinase (190 units/mg protein), 1 mM Lcysteine, 5-6 /xg supernatant protein, and other agents where indicated. Reactions were initiated by the addition of substrate (4 mM MgCl 2 , 1 mM GTP) and terminated by the addition of 0.9 ml of 50 mM sodium acetate (pH 4.0), followed by heating at 90° C for 3 minutes. Aliquots were assayed for cyclic GMP by radioimmunoassay.
Data from relaxation experiments and tissue cyclic GMP determinations are expressed as mean±SD. Data from guanylate cyclase experiments are expressed as mean ± SEM. EC50 values were determined graphically from each concentrationresponse curve. Differences were analyzed by the appropriate statistical test as indicated; p^0.05 was considered statistically significant.
Results
High-Dose Organic Nitrate Tolerance
In agreement with an earlier study, 13 GTN was approximately 10-fold and 100-fold more potent than D-IIDN and L-IIDN, respectively, for relaxation of isolated rat aortic strips ( Figure 2 ). Induction of tolerance in vitro by exposure to 0.5 mM GTN resulted in a rightward shift of the concentration-response curve for each of the three organic nitrates tested. However, the difference in potency between the three organic nitrates, and the enantiomeric difference for relaxation by r> and L-IIDN was lost in tolerant tissues ( Figure 2 ). The effect of high-dose GTN treatment on cyclic GMP accumulation was tested (Table 1) . Although basal cyclic GMP levels were unaffected by GTN pretreatment to induce tolerance, there was a marked attenuation of cyclic GMP accumulation after expo- Figure 2 ).
Low-Dose Organic Nitrate Tolerance
The protocol for low-dose organic nitrate tolerance was developed to compare the ability of various organic nitrates with different potencies to induce tolerance. Since the shift in sensitivity was not expected to be very great using this protocol, it was important to control for possible timedependent changes in the sensitivity of the preparation. As seen in Figure 3 , pretreatment of the tissues with diluent and buffer alone resulted in only a slight shift of the concentration-response curves to the right. The EC50 values for relaxation before and after such treatment were not significantly different (p>0.05, Student's t test for paired data). In contrast, treatment of blood vessels with any of the three organic nitrates resulted in a significant increase in the EC50 value for relaxation (Figure 4) . The EC30 value for relaxation was shifted by a factor of 3.1-fold, 5.4-fold, and 6.1-foldforGTN, D-UDN, and L-IIDN, respectively. However, these values are not significantly different when compared with each other (p>0.05, one-way analysis of variance).
Guanylate Cyclase Activity
Concentration-response curves for the activation of soluble guanylate cyclase prepared from nontolerant and high-dose GTN-tolerant rat aorta are shown in Figure 5 . Concentration-dependent increases in enzyme activity were observed in both GTNtolerant and control preparations in response to the organic nitrates and to sodium nitroprusside (SNP). Basal enzyme activity in control and GTN-tolerant preparations was not different (76 ±8 and 66 ±5 pmol cyclic GMP/mg protein/min, respectively; p>0.05, Student's t test for paired data). The EC50 values for enzyme activation in nontolerant preparations were SNP, 3.2±0. nitrovasodilators in GTN-pretreated tissues was significantly less than control at most drug concentrations tested ( Figure 5 ). At drug concentrations eliciting maximal activation, enzyme activity was decreased by approximately 75% in GTN-tolerant preparations.
These results suggest that a stable alteration of the enzyme occurred that survived homogenization of the tissue and centrifugation. An alternative explanation for the diminished guanylate cyclase activity in GTN-tolerant tissues is that factors inhibitory to guanylate cyclase may be present in different amounts in extracts from tolerant and nontolerant tissues. However, in a previous study from this laboratory, guanylate cyclase activity from GTN-tolerant and nontolerant rat aorta was studied in both supernatant fractions and supernatant from which guanylate cyclase was purified by immunoprecipitation with a monoclonal antibody specific for guanylate cyclase. 10 In GTN-pretreated tissues, enzyme activation by GTN, SNP, and nitric oxide was attenuated to a similar degree when either crude enzyme or immunoprecipitated enzyme was used. Since immmunoprecipitation would be expected to remove any inhibitory factors if present, it is unlikely that such interference could explain the decrease in guanylate cyclase activity in tolerant tissues.
Discussion
There appear to be at least two processes associated with the activation of guanylate cyclase and cyclic GMP accumulation induced by organic nitrates: biotransformation of organic nitrates and direct activation of guanylate cyclase. It was hypothesized by Needleman and Johnson 24 that organic nitrates interact with a specific SH group in the "organic nitrate receptor" and as a consequence of this interaction, relaxation ensues accompanied by denitration of the organic nitrate and oxidation of the SH group to the disulfide form. Others have suggested that activation of guanylate cyclase by organic nitrates involves release or formation of nitric oxide 12 -4 or S-nitrosothiols, 25 which then act as the proximal moieties for enzyme activation. In both cases, biotransformation of organic nitrates is a prerequisite for activation of guanylate cyclase.
Previous studies have demonstrated that in GTNtolerant vascular tissue, there is decreased biotransformation of GTN 5 and decreased activation of soluble guanylate cyclase, 9 ' 10 suggesting that both of these sites are affected by pretreatment of tissues with GTN. Insight into the relative contribution of these two mechanisms on the diminished vasodilator response to GTN has been obtained in experiments that examined cross-tolerance between GTN and the nitrovasodilator SNP. Concentrationresponse curves for relaxation induced by GTN in GTN-tolerant blood vessels were shifted to the right up to 750-fold compared with nontolerant tissues, while those for SNP were shifted no more than threefold.
7 " 12 Consistent with the different effect of these agents on relaxation in GTN-tolerant aorta, cyclic GMP accumulation induced by GTN was markedly attenuated in GTN-tolerant tissue, whereas cyclic GMP accumulation induced by SNP was only slightly decreased. 7 -11 This contrasts with results obtained in this study ( Figure 5 ) and in a previous study 10 in which activation by SNP and GTN of
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FIGURE 5. Effect of "high-dose" glyceryl trinitrate (GTN) treatment on activation of guanylate cyclase by sodium nitroprusside (SNP), GTN, D-isoidide dinitrate (D-IIDN), and L-isoidide dinitrate (L-IIDN). Experiments were performed as described in ' 'Materials and Methods.'' Basal enzyme activity in control (•) and GTN-tolerant (O) preparations was 76±9 and 66±5 pmol cyclic GMP/mg proteinlmin, respectively. Data points represent the mean±SEM of duplicate determinations of three preparations. Each preparation consisted of aorta pooled from three rats. Guanylate cyclase activity in GTN-tolerant preparations was significantly less than control at all concentrations of SNP, at concentrations of GTN>10 fj.M, and at concentrations of D-IIDN and L-IIDN>30 yM (p<0.05, Student's t test for paired data).
soluble guanylate cyclase obtained from GTNtolerant rat aorta was inhibited to a similar degree. These data suggest that, although there is desensitization of the enzyme to activation, there is sufficient enzyme activity remaining to permit SNPinduced cyclic GMP accumulation and relaxation to be near to control values. This implies that alteration of the metabolic activation of organic nitrates is a more important determinant for organic nitrateinduced tolerance than desensitization of guanylate cyclase to activation per se, and that the pathways leading to the formation of active species are different for organic nitrates than for SNP. Central to the above discussion is the question of the degree of guanylate cyclase activation required to produce sufficient cyclic GMP for relaxation. Evaluation of the literature is complicated by differences in experimental protocol with respect to the vascular preparation, the nature and concentration of the contractile agent, and the time of exposure to the relaxant compound. In experiments using rat or rabbit aorta, contracted submaximally with phenylephrine or norepinephrine and exposed to GTN for periods that elicited maximal cyclic GMP accumulation (30 seconds for rat aorta, 1.5-2 minutes for rabbit aorta), maximal or near maximal relaxation by GTN (0.1-1 /iM) was associated with threefold to sevenfold increases in cyclic GMP levels. 12152627 In another study in which aorta was contracted submaximally with norepinephrine and exposed to 0.1 ^M SNP, near maximal relaxation occurred with less than a twofold increase in cyclic GMP levels. 11 With higher concentrations of GTN or SNP, elevations of cyclic GMP of up to 300-fold have been reported, 7 " 12 indicating a large reserve capacity for enzyme activation. With lower concentrations of GTN or SNP, significant relaxation has been associated with statistically insignificant changes in cyclic GMP levels, 81526 suggesting that vascular smooth muscle is quite sensitive to small alterations in cyclic GMP. Indeed, changes in cyclic GMP-dependent protein phosphorylation occur at concentrations of SNP (5 nM) at which changes in tissue cyclic GMP levels would be difficult to discern. 28 To return to the question of whether there is sufficient enzyme activity remaining in GTNtolerant tissues to allow for SNP-induced cyclic GMP accumulation and relaxation, the above examples would suggest an affirmative answer because 1) there appears to be a large reserve capacity for enzyme activation, 2) modest increases in cyclic GMP levels can result in relaxation, and 3) approximately 25% of guanylate cyclase activity remains in GTN-tolerant tissues ( Figure 5) .
Although it is possible that the modest degree of cross-tolerance to SNP in GTN-pretreated tissues may be due to desensitization of guanylate cyclase by GTN, other sites (e.g., a site of GTN biotransformation to an active species) must be affected by GTN-pretreatment because much larger decreases in relaxation and cyclic GMP accumulation occur on subsequent reexposure to GTN than to SNP.
Although D-IIDN was about 10-fold more potent than L-IIDN for vascular smooth muscle relaxation and cyclic GMP accumulation, 15 the results of the present study demonstrate clearly that the two isomers were equipotent and were equally efficacious for activation of soluble guanylate cyclase ( Figure 5 ). In addition, the concentrations of organic nitrates that induce relaxation and cyclic GMP accumulation in intact tissues are approximately three orders of magnitude less than those that activate soluble guanylate cyclase in broken cell preparations. This would suggest that the mechanism of activation of guanylate cyclase by organic nitrates in intact tissues is different than that in broken cell preparations. In this regard, it has been demonstrated that in broken cell preparations, activation of soluble guanylate cyclase by organic nitrates requires the addition of cysteine, Nacetylcysteine, or thiosalicylic acid to the incubation medium, 29 -30 but there is no thiol requirement for organic nitrate-induced cyclic GMP accumulation in intact tissue. It has been demonstrated recently that cysteine reacts nonenzymatically with GTN, resulting in the liberation of nitric oxide, which then activates the enzyme. 31 The concentration of nitric oxide released from the reaction of millimolar concentrations of GTN with cysteine is in the high nanomolar range, 31 and is in agreement with the concentrations of nitric oxide required for enzyme activation. 3233 Thus, the high concentrations of organic nitrates required to activate guanylate cyclase in broken cell preparations can be explained by the rather inefficient formation of nitric oxide from the reaction of organic nitrates and cysteine. This process, or some other form of metabolic activation, is presumably much more efficient in intact cells, and therefore enzyme activation and subsequent relaxation occur at much lower concentrations of organic nitrates. It is of interest that the biotransformation of GTN during incubation with broken cell preparations from aortic tissue is exceedingly slow (3-4% in 8 hours) 34 as compared with that obtained when intact aorta is used (8.5% in 2 minutes). 5 Thus, the addition of thiols to broken cell preparations probably substitutes for some kind of metabolic activation process in intact tissues that is destroyed on homogenization of the tissue. Furthermore, the absence of enantioselectivity of IIDN for activation of guanylate cyclase in broken cell preparations would argue against a nonenzymatic reaction of organic nitrates with cysteine as the mechanism of enzyme activation in intact tissues.
Although it has been demonstrated that the biotransformation of GTN is attenuated in GTNtolerant tissues, 3 we wondered whether the enantioselectivity of IIDN for relaxation and cyclic GMP accumulation might be altered in tolerant tissues and whether this might reflect enantioselectivity in the biotransformation reaction. Induction of high-dose GTN tolerance resulted in rightward shifts of the concentration-response curves of approximately 5,000-fold, 400-fold, and 40-fold for GTN, D-IIDN, and L-I1DN, respectively (Figure 2 ). Furthermore, the enantioselectivity of IIDN and the potency difference between the three organic nitrates for relaxation seen in nontolerant aorta was absent in tolerant tissue. In fact, although D-IIDN was of intermediate potency in nontolerant aorta, it was the least potent organic nitrate in tolerant tissue, and was significantly less efficacious than GTN and L-IIDN. Cyclic GMP accumulation was examined at drug concentrations that elicited maximal relaxation in nontolerant tissue (GTN, 1 ^,M; r> and L-IIDN, 10 /xM). At these concentrations, cyclic GMP accumulation was increased significantly in nontolerant tissues, but not in GTN-tolerant tissues. In addition, cyclic GMP accumulation induced by 100 yM or 1 mM D-IIDN in GTN-tolerant tissues was significantly less than that induced by the same concentrations of L-IIDN (data not shown). In contrast, D-IIDN was more potent than the Lisomer for cyclic GMP accumulation in nontolerant blood vessels. 13 When activation of soluble guanylate cyclase was examined, there was a marked decrease in efficacy of the organic nitrates and of SNP for activation of enzyme from GTN-tolerant tissue, indicating that a stable alteration of the enzyme had occurred that survived homogenization of the tissue and centrifugation, as described previously. 10 However, in contrast to the data from the relaxation experiments, the EC50 for enzyme activation and the order of potency of GTN, D-IIDN, and L-IIDN was the same in enzyme preparations from tolerant or nontolerant tissues ( Figure 5 ). Again, this illustrates that activation of guanylate cyclase by organic nitrates is different in intact tissues and broken cell preparations. Together these data suggest that the site that determines the vasodilator potency of organic nitrates and enantioselectivity of organic nitrate action is lost when tissues are made tolerant to organic nitrates. Since decreased biotransformation of organic nitrates appears to be an important consequence of organic nitrate-induced tolerance, it is proposed that the site that determines enantioselectivity is a site of biotransformation.
Although the glutathione 5-transferases catalyze the denitration of organic nitrates in the liver, 35 these enzymes have not been isolated from vascular smooth muscle. It is of interest, however, that glutathione 5-transferases from liver and lung exhibit enantioselectivity for the conjugation of glutathione with polycyclic aromatic hydrocarbons and other compounds. 36 - 38 Biotransformation of GTN can also occur by interaction with hemoglobin and myoglobin, 3940 and there is regioselectivity in the denitration reaction in that there is a preferential formation of the 1,2-dinitrate metabolite over the 1,3-dinitrate metabolite. 40 This regioselectivity for denitration also occurs in rabbit aorta, 5 bovine pulmonary artery and vein, 41 and in several cultured cell lines. 42 It is therefore conceivable that vascular hemoproteins may participate in the biotransformation of organic nitrates and possibly enantioselective biotransformation. A third candidate is guanylate cyclase itself. Guanylate cyclase appears to contain a heme prosthetic group that can participate in enzyme activation. 43 Isoidide dinitrate could interact in an enantioselective manner with this heme group or with another part of the molecule. However, if this does occur in situ, tissue homogenization results in the loss of this property since the two isomers are equipotent for activation of guanylate cyclase in cell-free preparations. Since enantioselectivity of IIDN action is affected by GTN tolerance, identification of the site responsible for enantioselectivity and an understanding of its properties may suggest ways in which tolerance to organic nitrates could be prevented or reversed.
Tolerance to the vasodilator effect of IIDN has not been examined, and one of our objectives was to assess the relative potential of GTN, D-IIDN, and L -I I D N for inducing tolerance. The degree of in vitro tolerance induced by organic nitrates will depend on dose, potency, time of exposure, and length of time allowed for recovery. In the present experiments, a protocol was developed to compensate for the differences in vasodilator potency of the three organic nitrates, and to compensate for interanimal variation in sensitivity to a particular organic nitrate. Tolerance induced by this protocol resulted in a significant shift to the right of concentrationresponse curves for the three organic nitrates tested (Figure 4) . However, in each case the EC50 for relaxation was increased to a similar degree, indicating that the potential for inducing in vitro tolerance was the same for each of the agents tested. Whether D-IIDN will be a useful therapeutic agent for the prophylaxis or treatment of angina pectoris awaits the characterization of its hemodynamic and pharmacokinetic properties. The results of the present study suggest that tolerance induced by D-IIDN would be no greater than that induced by GTN.
Recent findings of Ahlner et al 4445 are of interest in the context of the present study. They describe a biphasic concentration-response curve for GTN in bovine mesenteric artery and suggest the existence of high-and low-affinity components for GTNinduced relaxation, both of which are mediated by cyclic GMP. 44 Furthermore, exposure of tissues to low GTN concentration (0.1 nM) for long time periods (8 hours) resulted in selective attenuation of the high affinity component, whereas exposure to high GTN concentration (0.1 mM) affected relaxation at all GTN concentrations. 43 Consistent with these observations, relaxation reached a plateau of 70-85% relaxation with GTN concentration in the micromolar range (Figure 4) , and although not shown, 100% relaxation could be obtained if GTN concentration was increased to the millimolar range.
The low-dose protocol for tolerance induction used in the present study resulted in rightward shifts in the concentration-response curves, but enantioselectivity and the potency difference between the organic nitrates was retained. On the other hand, high-dose GTN tolerance resulted in larger shifts in the concentration-response curves and a loss of enantioselectivity and the potency difference between the organic nitrates. Based on these findings, we propose that the high-affinity component for organic nitrate-induced relaxation is a site of biotransformation to an active species, which then activates guanylate cyclase. Organic nitrate action at this site is partially attenuated with low-dose organic nitrate pretreatment and completely lost with high-dose GTN-pretreatment. Consistent with the high concentration of organic nitrates needed for guanylate cyclase activation in cell-free preparations, and also the requirement for cysteine, the low affinity component for organic nitrateinduced relaxation may be the result of the nonenzymatic reaction of organic nitrates with cysteine leading to the generation of nitric oxide and subsequent activation of guanylate cyclase.
In summary, our results suggest that there are two sites at which organic nitrates act: guanylate cyclase and an unidentified site that determines the vasodilator potency and enantioselectivity of organic nitrate action and that is lost when tissues are made tolerant to organic nitrates. That the enantioselective site is a site of biotransformation is attractive since biotransformation of organic nitrates is related to relaxation, and in tolerant tissues both relaxation and biotransformation are attenuated and the enantioselectivity of organic nitrate action is lost.
